CardioConnect (tm), teleHealth, Heart health tracking-Steve Stephansen-09/19/2017 - 8:30am

Event Information
Event Topic: 
CardioConnect (tm), teleHealth, Heart health tracking
Event Date: 
09/19/2017 - 8:30am
Event Location: 
Sunnyvale City Council Chambers- 456 West Olive Ave., Sunnyvale
Speaker Information
Event Speaker: 
Steve Stephansen
Event Speaker Title: 
Event Speaker Company: 
LifeWave Biomedical
Event Speaker Bio: 

Steve Stephansen

Steve is the CEO of LifeWave Biomedical. Steve has 30 years of experience in the high tech industry, with a record of achievement in the commercialization of innovative technology products. His domain experience spans a number of areas, including semiconductor solutions for high-speed computing and signal processing, Internet video capture systems, and mobile application software.

He was previously CEO of WebV2, Inc. and Agoura Technologies. He held the position of VP of Marketing & Sales at Information Storage Devices and served in several senior marketing and sales positions at Advanced Micro Devices (AMD), including VP of Strategic Marketing for the $1B flash memory division.

He holds an MS in Management from the Stanford GSB, an MBA from Santa Clara University, an MSEE from Rensselaer Polytechnic Institute, and a BSEE from Lehigh University.

Event Details
Event Details: 

LifeWave Biomedical is developing a digital health product in value-based care, called the CardioConnect(tm) system, that improves the management of patients diagnosed with congestive heart failure (CHF) and respiratory/lung diseases in hospital, ambulatory, and home settings.

The solution consists of a small non-invasive sensor that will deliver accurate and absolute measurement of lung fluids and cardiorespiratory parameters with a brief daily assessment. The data is uploaded to a smartphone/tablet application and integrated with the patient’s drug regimen and other measured physiologic parameters to provide hospitalization decision support and to enhance patient self-management.

The CardioConnect integrates with artificial intelligence driven analytics and the development of a population health database. The clinical and economic benefits of the CardioConnect system are the improvement of patient quality-of-life, the potential extension of life expectancy, and the reduction of health care cost associated with initial hospital admissions and re-admissions.